Works matching DE "TYPE I interferons"
Results: 3003
Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1503559
- By:
- Publication type:
- Article
Integrated transcriptomic profiling reveals a STING-mediated Type II Interferon signature in SOD1-mutant amyotrophic lateral sclerosis models.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07790-w
- By:
- Publication type:
- Article
Editorial: Impact of the innate and adaptive immune system in driving type 1 inflammatory skin disease.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1568773
- By:
- Publication type:
- Article
The role of cGAS-STING pathway ubiquitination in innate immunity and multiple diseases.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1522200
- By:
- Publication type:
- Article
In Vitro Evaluation of the Antiviral Properties of Exogenous mRNA Encoding the Human MxA Protein.
- Published in:
- Microbiology Research, 2025, v. 16, n. 2, p. 32, doi. 10.3390/microbiolres16020032
- By:
- Publication type:
- Article
A family cluster of persistent Pandoraea vervacti infection in cystic fibrosis.
- Published in:
- Journal of Immunoassay & Immunochemistry, 2025, v. 46, n. 2, p. 201, doi. 10.1080/15321819.2025.2462807
- By:
- Publication type:
- Article
Frk positively regulates innate antiviral immunity by phosphorylating TBK1.
- Published in:
- Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2025.1525648
- By:
- Publication type:
- Article
Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1529582
- By:
- Publication type:
- Article
IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1525083
- By:
- Publication type:
- Article
Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1563383
- By:
- Publication type:
- Article
Successful Treatment of Severe Dystrophic Nail Psoriasis With Deucravacitinib.
- Published in:
- Cutis, 2024, v. 114, n. 6, p. 196, doi. 10.12788/cutis.1142
- By:
- Publication type:
- Article
Long Non-Coding RNA THRIL Promotes Influenza Virus Replication by Inhibiting the Antiviral Innate Immune Response.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 153, doi. 10.3390/v17020153
- By:
- Publication type:
- Article
The Role of Sustained Type I Interferon Secretion in Chronic HIV Pathogenicity: Implications for Viral Persistence, Immune Activation, and Immunometabolism.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 139, doi. 10.3390/v17020139
- By:
- Publication type:
- Article
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
- Published in:
- PLoS Biology, 2025, v. 23, n. 1, p. 1, doi. 10.1371/journal.pbio.3002982
- By:
- Publication type:
- Article
The Toxoplasma oxygen-sensing protein, TgPhyA, is required for resistance to interferon gamma-mediated nutritional immunity in mice.
- Published in:
- PLoS Biology, 2024, v. 22, n. 6, p. 1, doi. 10.1371/journal.pbio.3002690
- By:
- Publication type:
- Article
Editorial.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 1, p. 1, doi. 10.1111/vco.12564
- By:
- Publication type:
- Article
The potential of the combined use of targeted type I interferon pathway inhibitors and oncolytic viruses to treat sarcomas.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 1, p. 36, doi. 10.1111/vco.12547
- By:
- Publication type:
- Article
Anti‐tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 184, doi. 10.1111/vco.12468
- By:
- Publication type:
- Article
Photoactivated DNA Assembly and Disassembly for On‐Demand Activation and Termination of cGAS‐STING Signaling.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 33, p. 1, doi. 10.1002/ange.202305837
- By:
- Publication type:
- Article
An Ion‐Enhanced Oncolytic Virus‐Like Nanoparticle for Tumor Immunotherapy.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 45, p. 1, doi. 10.1002/ange.202210487
- By:
- Publication type:
- Article
Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 18, p. 10260, doi. 10.1002/ange.202016805
- By:
- Publication type:
- Article
Isolated cutaneous panniculitis in Sjögren's disease exacerbated by COVID-19 illness.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 8, p. 2403, doi. 10.1007/s10067-024-07046-8
- By:
- Publication type:
- Article
Potential relevance of type I interferon-related biomarkers for the management of polygenic autoimmune rheumatic diseases with childhood onset.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 7, p. 1733, doi. 10.1007/s10067-023-06645-1
- By:
- Publication type:
- Article
Identification of potential biomarkers for systemic lupus erythematosus by integrated analysis of gene expression and methylation data.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 5, p. 1423, doi. 10.1007/s10067-022-06495-3
- By:
- Publication type:
- Article
Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 6, p. 1719, doi. 10.1007/s10067-021-06035-5
- By:
- Publication type:
- Article
Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 2, p. 437, doi. 10.1007/s10067-021-05913-2
- By:
- Publication type:
- Article
Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 8, p. 3027, doi. 10.1007/s10067-020-05526-1
- By:
- Publication type:
- Article
Variations in the attachments of the medial meniscal anterior horn: a descriptive cadaveric study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein.
- Published in:
- Virus Genes, 2023, v. 59, n. 2, p. 215, doi. 10.1007/s11262-022-01958-w
- By:
- Publication type:
- Article
SOX9 negatively regulates the RLR antiviral signaling by targeting MAVS.
- Published in:
- Virus Genes, 2022, v. 58, n. 2, p. 122, doi. 10.1007/s11262-022-01886-9
- By:
- Publication type:
- Article
Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.
- Published in:
- Virus Genes, 2019, v. 55, n. 5, p. 610, doi. 10.1007/s11262-019-01689-5
- By:
- Publication type:
- Article
MicroRNA‐218 inhibits type I interferon production and facilitates virus immune evasion via targeting RIG‐I.
- Published in:
- Biotechnology & Applied Biochemistry, 2020, v. 67, n. 3, p. 396, doi. 10.1002/bab.1882
- By:
- Publication type:
- Article
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00702-1
- By:
- Publication type:
- Article
An effective live-attenuated Zika vaccine candidate with a modified 5′ untranslated region.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00650-w
- By:
- Publication type:
- Article
The immunological interplay between vaccination and the intestinal microbiota.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00627-9
- By:
- Publication type:
- Article
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00583-w
- By:
- Publication type:
- Article
IRF7 -deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.13989
- By:
- Publication type:
- Article
Overexpression of the recombinant human interferon-beta (rhIFN-β) gene in tobacco chloroplasts.
- Published in:
- Biotechnologia, 2021, v. 102, n. 4, p. 367, doi. 10.5114/bta.2021.111094
- By:
- Publication type:
- Article
Decoding the pathogenesis of Diamond–Blackfan anemia using single-cell RNA-seq.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00389-z
- By:
- Publication type:
- Article
Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.
- Published in:
- Cell Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41421-021-00329-3
- By:
- Publication type:
- Article
Influence of İnterferon α-2a Treatment on Monocyte Subsets in Patients with Uveitis.
- Published in:
- Turkish Journal of Immunology, 2020, v. 8, n. 2, p. 50, doi. 10.25002/tji.2020.1261
- By:
- Publication type:
- Article
Adenosine regulation of danger signaling.
- Published in:
- Turkish Journal of Immunology, 2016, v. 4, p. 72
- By:
- Publication type:
- Article
Helicobacter pylori Infection Elicits Type I Interferon Response in Human Monocytes via Toll-Like Receptor 8 Signaling.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Pharmacologically Active Alkaloid Cryptolepine Activates a Type 1 Interferon Response That Is Independent of MAVS and STING Pathways.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acute activation of bronchopulmonary vagal nociceptors by type I interferons.
- Published in:
- Journal of Physiology, 2020, v. 598, n. 23, p. 5541, doi. 10.1113/JP280276
- By:
- Publication type:
- Article
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 10, p. 2827, doi. 10.1007/s13555-024-01262-5
- By:
- Publication type:
- Article
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 3, p. 733, doi. 10.1007/s13555-021-00517-9
- By:
- Publication type:
- Article
Protective effect of interferon type I on barrier function of human airway epithelium during rhinovirus infections in vitro.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-82516-2
- By:
- Publication type:
- Article